Enrolment of the first paediatric cohort into the Australian lupus registry and biobank: A single-centre experience

Abstract

Introduction

We aim to report on the feasibility of establishment of the first paediatric cohort as part of the longitudinal database of the Australian Lupus Registry and Biobank (ALRB) and to describe the enrolment data with a focus on clinical characteristics, serological data, treatment strategies and patient/parent-reported outcome measures.

Methods

All patients under the age of 18 years with a diagnosis of systemic lupus erythematosus (SLE) attending the paediatric rheumatology service of a single, tertiary hospital were identified. Patients were enrolled in the ALRB if they met ≥4/11 of the American College of Rheumatology (ACR) 1997 SLE classification criteria or the Systemic Lupus International Collaborating Clinics (SLICC) 2012 classification criteria. Enrolment data including demographics, clinical characteristics, serological profiles, disease activity and damage assessments were recorded. Peds-QL Rheumatology and General Modules were used to assess patient and parent-reported outcomes.

Results

Twenty-seven patients were eligible for inclusion, with 26 patients (96%) consenting for enrolment. Twenty-five patients (92%) consented for biobanking. Twenty patients (77%) were female. The median age at enrolment was 16 years (interquartile range (IQR) 13.7, 17.4). The median disease duration from diagnosis was 3.2 years (IQR 1.4, 5.3). Sixteen patients (62%) had synovitis, 16 (62%) had cutaneous involvement, 4 (15%) had serositis, 17 (65%) had haematological involvement and 7 (27%) had renal involvement at enrolment. Nineteen patients (73%) were prescribed at least two disease-modifying anti-rheumatic medications (DMARDs). Hydroxychloroquine (n = 22, 85%) and mycophenolate mofetil (n = 9, 35%) were the most commonly prescribed DMARDs. The median SLEDAI-2K score was 2 (IQR 2, 4). Six patients (23%) had active disease (SLEDAI-2K ≥6) at enrolment. Three patients (11.5%) had reported damage using the SLICC/ACR Damage Index. Twenty-three children (88%) and eighteen parents (69%) completed the Paediatric Quality of Life Inventory. Quality of life scores reported across domains of physical, emotional, social and school functioning at enrolment were comparable to previously studied paediatric cohorts with SLE and other chronic diseases.

Conclusion

We have established our centre as the first paediatric participating site of the ALRB, providing contemporary data on the clinical characteristics, serological profile and health-related quality of life outcomes of Australian children with SLE. Paediatric involvement with this national registry will provide a unique perspective for future clinical and scientific research. Collection of Australian-specific paediatric longitudinal data will also enable a broader understanding of SLE within a multicultural Australian population.

Keywords

Systemic lupus erythematosus paediatric registry biobank Australia

Get full access to this article

View all access options for this article.

References

Zucchi

Elefante

Calabresi

, et al. One year in review 2019: systemic lupus erythematosus. Clin Exp Rheumatol 2019; 37(5): 715–722.

Stojan

Petri

. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol 2018; 30(2): 144–150.

Rees

Doherty

Grainge

, et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford) 2017; 56(11): 1945–1961.

Nikpour

Bridge

Richter

. A systematic review of prevalence, disease characteristics and management of systemic lupus erythematosus in Australia: identifying areas of unmet need. Intern Med J 2014; 44(12a): 1170–1179.

Tucker

Menon

Schaller

, et al. Adult- and childhood-onset systemic lupus erythematosus: a comparison of onset, clinical features, serology, and outcome. Br J Rheumatol 1995; 34(9): 866–872.

Font

Cervera

Espinosa

, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 1998; 57(8): 456–459.

Charras

Smith

Hedrich

. Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep 2021; 23(3): 20.

Kamphuis

Silverman

. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol 2010; 6(9): 538–546.

Artim-Esen

Şahin

Çene

, et al. Comparison of disease characteristics, organ damage, and survival in patients with juvenile-onset and adult-onset systemic lupus erythematosus in a combined cohort from 2 tertiary centers in Turkey. J Rheumatol 2017; 44(5): 619–625.

10.

das Chagas Medeiros

Bezerra

Braga

FNHF

, et al. Clinical and immunological aspects and outcome of a Brazilian cohort of 414 patients with systemic lupus erythematosus (SLE): comparison between childhood-onset, adult-onset, and late-onset SLE. Lupus 2016; 25(4): 355–363.

11.

Kim

Levy

Silverman

, et al. A comparison between childhood and adult onset systemic lupus erythematosus adjusted for ethnicity from the 1000 Canadian Faces of Lupus Cohort. Rheumatology (Oxford). 2019; 58: 1393–1399.

12.

Brunner

Gladman

Ibañez

, et al. Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum 2008; 58(2): 556–562.

13.

Joo

Park

S-Y

Won

, et al. Differences in clinical features and mortality between childhood-onset and adult-onset systemic lupus erythematosus: a prospective single-center study. J Rheumatol 2016; 43(8): 1490–1497.

14.

Bundhun

Kumari

Huang

. Differences in clinical features observed between childhood-onset versus adult-onset systemic lupus erythematosus: a systematic review and meta-analysis. Medicine (Baltimore) 2017; 96(37): e8086.

15.

Livingston

Bonner

Pope

. Differences in clinical manifestations between childhood-onset lupus and adult-onset lupus: a meta-analysis. Lupus 2011; 20(13): 1345–1355.

16.

L-J

Wallace

Navarra

, et al. Lupus registries: evolution and challenges. Semin Arthritis Rheum 2010; 39(4): 224–245.

17.

Our network - ERN ReCONNET | European reference network on rare and complex connective tissue and musculoskeletal diseases [Internet]. [cited 2022 May 27]. Available from: https://reconnet.ern-net.eu/our-network/

18.

National lupus patient registry | lupus foundation of America [Internet]. [cited 2022 May 27]. Available from: https://www.lupus.org/national-lupus-patient-registry

19.

Kandane-Rathnayake

Golder

Louthrenoo

, et al. Development of the Asia pacific lupus collaboration cohort. Int J Rheum Dis 2019; 22(3): 425–433.

20.

Torrente-Segarra

Salman Monte

Rúa-Figueroa

, et al. Relationship between damage and mortality in juvenile-onset systemic lupus erythematosus: cluster analyses in a large cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER). Semin Arthritis Rheum 2019; 48(6): 1025–1029.

21.

Bacha

Knight

Schanberg

, et al. 1110 Overview of the childhood systemic lupus erythematosus (cSLE) cohort in the CARRA registry. Abstracts. Lupus Foundation of America 2021, pp. A37–A38.

22.

O’Neill

Morand

Hoi

. The Australian lupus registry and biobank: a timely initiative. Med J Aust 2017; 206(5): 194–195.

23.

Touma

Urowitz

Taghavi-Zadeh

, et al. Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months. Rheumatology (Oxford) 2012; 51(10): 1814–1819.

24.

Pincus

Castrejon

Chua

, et al. AB1173 Physician visual analog scale estimates for overall global assessment, inflammation, damage, and distress to assess patients and support clinical decisions in routine rheumatology care: analysis of inter-rater reliability. Abstracts Accepted for Publication. BMJ Publishing Group Ltd and European League Against Rheumatism 2017, pp. 1466.2–1466.

25.

Buyon

Petri

Kim

, et al. The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005; 142(12 Pt 1): 953–962.

26.

Varni

Seid

Rode

. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care 1999; 37(2): 126–139.

27.

Varni

Seid

Smith Knight

, et al. The PedsQL in pediatric rheumatology: reliability, validity, and responsiveness of the pediatric quality of life inventory generic core scales and rheumatology module. Arthritis Rheum 2002; 46(3): 714–725.

28.

Cann

Sage

McKinnon

, et al. Childhood systemic lupus erythematosus: presentation, management and long-term outcomes in an Australian cohort. Lupus 2022; 31(2): 246–255.

29.

Salah

Lotfy

Mokbel

, et al. Damage index in childhood-onset systemic lupus erythematosus in Egypt. Pediatr Rheumatol Online J 2011; 9(1): 36.

30.

Sit

JKK

Chan

WKY

. Risk factors for damage in childhood-onset systemic lupus erythematosus in Asians: a case control study. Pediatr Rheumatol Online J 2018; 16(1): 56.

31.

Watson

Leone

Pilkington

, et al. Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort. Arthritis Rheum 2012; 64(7): 2356–2365.

32.

Moorthy

Peterson

MGE

Harrison

, et al. Quality of life in children with systemic lupus erythematosus: a review. Lupus 2007; 16(8): 663–669.

33.

PedsQL TM (Pediatric quality of life inventory TM) [Internet]. [cited 2022 Sep 11]. Available from: https://www.pedsql.org/about_pedsql.html

34.

Hersh

. Measures of health-related quality of life in pediatric systemic lupus erythematosus: Childhood Health Assessment Questionnaire (C-HAQ), Child Health Questionnaire (CHQ), Pediatric Quality of Life Inventory Generic Core Module (PedsQL-GC), Pediatric Quality of Life Inventory Rheumatology Module (PedsQL-RM), and Simple Measure of Impact of Lupus Erythematosus in Youngsters (SMILEY). Arthritis Care Res (Hoboken) 2011; 63(Suppl 11): S446–S453.

35.

Varni

Burwinkle

Seid

. The PedsQL 4.0 as a school population health measure: feasibility, reliability, and validity. Qual Life Res 2006; 15(2): 203–215.

36.

Catchpool

Gold

Grobler

, et al. Health-related quality of life: population epidemiology and concordance in Australian children aged 11-12 years and their parents. BMJ Open 2019; 9(Suppl 3): 157–164.

37.

Moorthy

Harrison

Peterson

, et al. Relationship of quality of life and physical function measures with disease activity in children with systemic lupus erythematosus. Lupus 2005; 14(4): 280–287.

38.

Silva

Seixas

RBPM

de Carvalho

. Quality of life in children and adolescents with inflammatory bowel disease: impact and predictive factors. Pediatr Gastroenterol Hepatol Nutr 2020; 23(3): 286–296.

39.

Varni

Burwinkle

Katz

, et al. The PedsQL in pediatric cancer: reliability and validity of the pediatric quality of life inventory generic core scales, multidimensional fatigue scale, and cancer module. Cancer 2002; 94(7): 2090–2106.

40.

Berkes

Pataki

Kiss

, et al. Measuring health-related quality of life in Hungarian children with heart disease: psychometric properties of the Hungarian version of the pediatric quality of life inventory 4.0 generic core scales and the cardiac module. Health Qual Life Outcomes 2010; 8: 14.